Search Results - "Abakumova, Tatyana V"

The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer by Gening, Snezhanna O., Abakumova, Tatyana V., Gafurbaeva, Dina U., Rizvanov, Albert A., Antoneeva, Inna I., Miftakhova, Regina R., Peskov, Andrey B., Gening, Tatyana P.

“…Stem properties allow circulating tumor cells (CTCs) to survive in the bloodstream and initiate cancer progression. We aimed to assess the numbers of stem-like…”
Get full text

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response by Antoneeva, Inna I, Abakumova, Tatyana V, Dolgova, Dinara R, Gening, Tatyana P, Pirmamedova, Sabina S, Myasnikova, Dinara F, Gening, Snezhanna O

“…Polychemotherapy in ovarian cancer (OC) is the second major component of treatment. However, treatment with cytostatics is stopped in 25% of cases because of…”
Get more information

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer by Antoneeva, Inna I, Dolgova, Dinara R, Gening, Tatyana P, Abakumova, Tatyana V, Gening, Snezhanna O, Pirmamedova, Sabina S, Fomina, Anastasia V, Mikheenko, Alla A

“…Ovarian cancer (OC) is the most lethal of gynecologic tumors because women generally present with advanced stage disease. Platinum-based chemotherapy play a…”
Get more information

Relationship Between Serum Cytokine Profile and Circulating Neutrophils Phenotype in Patients with Benign Ovarian Tumors and Ovarian Cancer by Abakumova, Tatyana V., Gening, Snezhanna O., Gening, Tatyana P.

“…Changes in the cytokine microenvironment determine the anti- (N1) and pro-tumor (N2) activity of neutrophils (Nph), which has been shown in multiple in vitro…”
Get full text

Predictive value of inflammatory regulators TGFb1 and CXCL8 in tumor tissue in colorectal cancer by Bogomolova, I. A., Dolgova, D. R., Antoneeva, I. I., Abakumova, T. V., Myagdieva, I. R., Peskov, A. B., Gening, T. P.

“…Background. Colorectal cancer is ranked third in terms of incidence and second in terms of mortality around the world. Molecular markers of chemoresistance…”
Get full text

Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients by Dolgova, D. R., Gening, T. R., Abakumova, T. V., Gening, S. O., Antoneeva, I. I., Fedotova, A. Yu

“…Background. Chemotherapy is one of the main types of treatment in ovarian cancer. Standard first-line treatment includes platinum drugs. Every fifth patient…”
Get full text